DNE PHARMA AS

1086 OSLO

Finances

Return on Equity

12,93 %

Current Ratio

1,39

Debt-to-Equity Ratio

0,17

Key figures (NOK)	2022	2021	2020	2019
Revenue	46 745 000	40 374 000	31 713 000	28 168 000
Net Income	6 837 000	5 000 000	−14 371 000	−3 561 000
Total Assets	91 487 000	75 668 000	76 926 000	62 151 000
Total Equity	52 863 000	46 026 000	41 296 000	43 908 000

Income (NOK)	2022	2021	2020	2019
Revenue	46 745 000	40 374 000	31 713 000	28 168 000
Expenditure	37 643 000	33 578 000	31 104 000	34 823 000
Operating Profit	9 102 000	6 796 000	610 000	−6 656 000
Financial Income	1 618 000	1 542 000	1 791 000	3 289 000
Financial Costs	2 158 000	2 053 000	16 436 000	1 184 000
Financial Balance	−540 000	−511 000	−14 645 000	2 105 000
Earnings Before Tax	8 562 000	6 285 000	−14 034 000	−4 550 000
Tax	1 725 000	1 285 000	337 000	−990 000
Net Income	6 837 000	5 000 000	−14 371 000	−3 561 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	50 422 000	41 740 000	56 847 000	36 688 000
Total Current Assets	41 065 000	33 928 000	20 079 000	25 463 000
Total Assets	91 487 000	75 668 000	76 926 000	62 151 000
Total Retained Equity	51 384 000	44 547 000	39 817 000	42 878 000
Total Equity	52 863 000	46 026 000	41 296 000	43 908 000
Total Long-Term Debt	8 989 000	9 421 000	9 576 000	3 792 000
Total Current Debt	29 635 000	20 220 000	26 054 000	14 451 000
Total Equity and Debt	91 487 000	75 668 000	76 926 000	62 151 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	46 724 000	40 356 000	31 491 000	27 140 000
Other Income	22 000	18 000	222 000	1 028 000
Revenue	46 745 000	40 374 000	31 713 000	28 168 000
Cost of Goods Sold	12 394 000	10 771 000	9 230 000	8 761 000
Salary Costs	7 165 000	8 203 000	7 310 000	10 867 000
Depreciation	2 543 000	3 487 000	3 088 000	1 589 000
Impairment	0	0	70 000	0
Expenditure	37 643 000	33 578 000	31 104 000	34 823 000
Operating Profit	9 102 000	6 796 000	610 000	−6 656 000
Financial Income	1 618 000	1 542 000	1 791 000	3 289 000
Financial Costs	2 158 000	2 053 000	16 436 000	1 184 000
Financial Balance	−540 000	−511 000	−14 645 000	2 105 000
Dividends	0	0	0	0
Net Income	6 837 000	5 000 000	−14 371 000	−3 561 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	32 626 000	35 835 000	38 821 000	24 060 000
Real Eastate	0	0	0	0
Machinery and Plant Facilities	102 000	167 000	231 000	296 000
Fixtures	50 000	95 000	951 000	1 582 000
Total Tangible Assets	152 000	262 000	1 183 000	1 877 000
Total Fiancial Fixed Assets	17 643 000	5 643 000	16 843 000	10 750 000
Total Fixed Assets	50 422 000	41 740 000	56 847 000	36 688 000
Stock	9 377 000	8 734 000	9 690 000	6 093 000
Total Investments	0	0	0	0
Cash, Bank	8 635 000	8 011 000	3 329 000	7 943 000
Total Current Assets	41 065 000	33 928 000	20 079 000	25 463 000
Total Assets	91 487 000	75 668 000	76 926 000	62 151 000
Total Equity	52 863 000	46 026 000	41 296 000	43 908 000
Short-Term Group Debt	0	0	0	0
Total Long-Term Debt	8 989 000	9 421 000	9 576 000	3 792 000
Creditors	1 587 000	1 069 000	2 162 000	987 000
Unpaid Taxes	1 537 000	1 921 000	1 560 000	704 000
Dividends	0	0	0	0
Other Current Debt	12 901 000	14 818 000	22 332 000	12 760 000
Total Current Debt	29 635 000	20 220 000	26 054 000	14 451 000
Total Equity and Debt	91 487 000	75 668 000	76 926 000	62 151 000

Financial indicators	2022	2021	2020	2019
Return on Equity	12,93 %	10,86 %	−34,8 %	−8,11 %
Debt-to-Equity Ratio	0,17	0,2	0,23	0,09
Operating Profit Margin	19,47 %	16,83 %	1,92 %	−23,63 %
Current Ratio	1,39	1,68	0,77	1,76
Quick Ratio	2,03	2,95	1,23	3,05
Equity Ratio	0,58	0,61	0,54	0,71
Gross Profit Margin	73,49 %	73,32 %	70,9 %	68,9 %